National Cancer Institute - U.S. National Institutes of Health - www.cancer.govSkip navigationNational Cancer Institute - U.S. National Institutes of Health - www.cancer.govClinical Trials at NIH - Be part of the cure
National Cancer Institute - U.S. National Institutes of Health - www.cancer.gov
Clinical Trials at NIH Home

Search for CCR Trials at NIH


Xeroderma Pigmentosum

Cancer Risk in Xeroderma Pigmentosum Heterozygotes

NCI-02-C-0313, NCT00049621

Print this page 


Investigator(s):

Kenneth H. Kraemer, M.D.
Principal Investigator
Phone: 301-496-9033
kraemerk@nih.gov

Referral Contact(s):

Deborah Tamura, M.S., R.N.
Research Nurse
Phone: 301-594-5030
Fax: 301-594-3409
tamurad@mail.nih.gov

 

Key Eligibility Criteria:

  • One of the following:
    • Blood relative of a patient diagnosed with xeroderma pigmentosum (XP)
    • Spouse of a blood relative of a patient with XP
    • Spouse of a patient with XP
    • Family member of a patient with clinical documentation of features of XP and laboratory determination of DNA repair defect or newly diagnosed on other approved protocols
    • Evaluation of proband at the Warren Grant Magnuson Clinical

    Study Outline:

    • Patients undergo general cancer screening comprising medical history and physical exam, including skin and neurologic examination
    • Laboratory samples are collected for review
    • Patients are followed annually by telephone or mail to determine clinical status

    Additional Information:

    • This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements, regardless of where they live in the United States.
    • There is no charge for medical care received at NIH Clinical Center.
    • PDQ (Physicians Data Query) - provides additional details about this study for health care providers.


    Reviewed: 12/27/12
    Updated: 3/1/07

Back to Top